Efalizumab |
| Catalog No.GC69041 |
Efalizumab is a targeted T-cell modulator, which is a humanized monoclonal antibody against the LFA-1 alpha subunit CD11a. Efalizumab can inhibit T-cell activation, skin T-cell trafficking and T-cell adhesion to keratinocytes, and can be used in research on plaque psoriasis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 214745-43-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Efalizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Efalizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *